For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Immuneering Corp’s stock clocked out at $3.44, up 2.08% from its previous closing price of $3.37. In other words, the price has increased by $2.08 from its previous closing price. On the day, 0.83 million shares were traded. IMRX stock price reached its highest trading level at $3.565 during the session, while it also had its lowest trading level at $3.22.
Ratios:
To gain a deeper understanding of IMRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.48 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
On March 15, 2024, Needham reiterated its Buy rating and also upped its target price recommendation from $20 to $15.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 27 ’25 when Schall Thomas J. bought 9,500 shares for $3.66 per share. The transaction valued at 34,788 led to the insider holds 52,885 shares of the business.
Hall Brett Matthew bought 7,415 shares of IMRX for $20,020 on Jun 20 ’25. The CHIEF SCIENTIFIC OFFICER now owns 353,311 shares after completing the transaction at $2.70 per share. On Jun 23 ’25, another insider, Hall Brett Matthew, who serves as the CHIEF SCIENTIFIC OFFICER of the company, bought 6,007 shares for $2.43 each. As a result, the insider paid 14,596 and bolstered with 359,318 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMRX now has a Market Capitalization of 123790808 and an Enterprise Value of 89488840.
Stock Price History:
The Beta on a monthly basis for IMRX is 0.37, which has changed by 2.0442479 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, IMRX has reached a high of $3.87, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is 86.57%, while the 200-Day Moving Average is calculated to be 78.76%.
Shares Statistics:
It appears that IMRX traded 1.04M shares on average per day over the past three months and 5256340 shares per day over the past ten days. A total of 35.99M shares are outstanding, with a floating share count of 25.84M. Insiders hold about 28.19% of the company’s shares, while institutions hold 12.50% stake in the company. Shares short for IMRX as of 1749772800 were 893835 with a Short Ratio of 0.86, compared to 1747267200 on 660772. Therefore, it implies a Short% of Shares Outstanding of 893835 and a Short% of Float of 3.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
